Waker Bioscience leads the way in providing safety assessment of cell and gene therapy drug products based on our proprietary LTA-PCR technology to enable pharmaceutical clients to develop novel cell and gene therapies that meet regulatory safety requirements. As a full-service provider, we mainly provides Integration Site Analysis, On-/Off-Target Analysis, Vector Copy Number, and Vector Quality Control services.
Core Services：
Validated LTA-PCR for ISA ( Ligation targeted amplification PCR for Integration Site Analysis )
CRISPR On/Off-Target Assessment
NGS-Based AAV batch quality control
NGS-based Cell line Identification
VCN(vector copy number)
RCL ( qPCR or Cell Culture-based Method )
Assay qualification and validation
Company Details
- Employees
- 2
- Founded
- -
- Address
- 10 Oasis Ring Rd,minhang District, 402a,china
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://en.wakerbio.com/
- Keywords
- provider.
- HQ
- Shanghai, Shanghai
- Competitors
- HEYDUDE, Alexander Group, Niba Labs, ProtaGene.
Waker Bioscience Questions
Waker Bioscience's website is http://en.wakerbio.com/
Waker Bioscience's LinkedIn profile is https://cn.linkedin.com/company/shanghai-waker-bioscience-co-ltd
Waker Bioscience has
2 employees.
View email and phone details for 2
employees at Waker Bioscience.
Waker Bioscience's industry is
Biotechnology Research
Waker Bioscience's categories are Biotechnology Research
Waker Bioscience's founding year is 2021
